TJ Powles
71 works · 2,690 citations · h-index 23
Top works
- c-erbB-2 expression in benign and malignant breast disease
- Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.
- 984 Chemoprevention of breast cancer with tamoxifen
- Use of the aromatase inhibitor 4-hydroxyandrostenedione in postmenopausal breast cancer: optimization of therapeutic dose and route.
- Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
- Clinical examination, xeromammography, and fine-needle aspiration cytology in diagnosis of breast tumours.
- Immunocytochemical assay for estrogen receptor: relationship to outcome of therapy in patients with advanced breast cancer.
- A randomised trial comparing combination chemotherapy using mitomycin C, mitozantrone and methotrexate (3M) with vincristine, anthracycline and cyclophosphamide (VAC) in advanced breast cancer
- The influence of aminoglutethimide and its analogue rogletimide on peripheral aromatisation in breast cancer
- Postmenopausal estrogen synthesis and metabolism: Alterations caused by aromatase inhibitors used for the treatment of breast cancer
- The influence of CGS 16949A on peripheral aromatisation in breast cancer patients
- Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer.
- Vindesine: a phase II study in the treatment of breast carcinoma, malignant melanoma, and other tumors.
- Fine Needle Aspiration Cytodiagnosis As A Pre‐Requisite For Primary Medical Treatment of Breast Cancer
- Breast Cancer Incidence in the Randomized PEARL Trial of Lasofoxifene in Postmenopausal Osteoporotic Women
- Adjuvant aminoglutethimide for postmenopausal patients with primary breast cancer: analysis at 8 years.
- Adjuvant aminoglutethimide therapy for postmenopausal patients with primary breast cancer.
- A method for assessing the quality of life of cancer patients: replication of the factor structure
- Detection of bone metastases in patients with breast cancer.
- Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients